Results 21 to 30 of about 2,590,210 (272)

Multimodal CEA-targeted fluorescence and radioguided cytoreductive surgery for peritoneal metastases of colorectal origin

Nature Communications, 2022
In patients with colorectal peritoneal metastases scheduled for cytoreductive surgery, accurate preoperative estimation of tumor burden and subsequent intraoperative detection of all tumor deposits remains challenging.
J. D. de Gooyer, F. M. Elekonawo, A. Bremers, O. Boerman, E. Aarntzen, P. D. de Reuver, I. Nagtegaal, M. Rijpkema, J. D. de Wilt   +8 more
semanticscholar   +1 more source

Feasibility of a Multimodal Prehabilitation Programme in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer: A Pilot Study

Cancers, 2022
Simple Summary Multimodal prehabilitation programmes represent an innovative approach to promoting surgical recovery by improving the physiological and psychological baseline resilience in conjunction with nutritional optimisation in order to reduce the ...
B. Díaz-Feijóo, Nuria Agusti-Garcia, Raquel Sebio, A. López-Hernández, Marina Sisó, A. Glickman, Núria Carreras-Dieguez, P. Fusté, T. Marina, Judit Martínez-Egea, Laura Aguilera, J. Perdomo, Amaia Peláez, M. López-Baamonde, R. Navarro-Ripoll, E. Gimeno, Betina Campero, A. Torné, G. Martínez-Pallí, M. Arguis   +19 more
semanticscholar   +1 more source

Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique

BMC Surgery, 2021
Background This study investigated the feasibility and safety of laparoscopic splenectomy conducted in the contexts of both laparoscopic secondary surgery for isolated recurrence in the spleen and primary laparoscopic cytoreductive surgery for advanced ...
Antonio Macciò, Elisabetta Sanna, Fabrizio Lavra, Giacomo Chiappe, Marco Petrillo, Clelia Madeddu   +5 more
doaj   +1 more source

Quality of life outcomes from the randomized trial of hyperthermic intraperitoneal chemotherapy following cytoreductive surgery for primary ovarian cancer (KOV-HIPEC-01)

Journal of Gynecologic Oncology, 2022
Objective To investigate the health-related quality of life (HRQOL) related to hyperthermic intraperitoneal chemotherapy (HIPEC) following primary or interval cytoreductive surgery for primary ovarian cancer. Methods Between 2010 and 2016, a total of 184
J. Kim, Dong-eun Lee, Yumi Lee, H. I. Ha, Y. Chang, Suk-Joon Chang, Sang-Yoon Park, M. Lim   +7 more
semanticscholar   +1 more source

Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis

Journal of Clinical Oncology, 2021
PURPOSE The survival impact of secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer was studied. METHODS We identified published studies from 1983 to 2021 following our inclusion criteria from MEDLINE, EMBASE, and ...
M. Baek, E. Park, H. I. Ha, S. Park, M. Lim, C. Fotopoulou, R. Bristow   +6 more
semanticscholar   +1 more source

Surgical outcomes of ureteral reconstruction during cytoreductive surgery for ovarian cancer: a retrospective cohort study

BMC Cancer, 2022
Background Ureteral reconstruction is required after surgical resection of the tumor invading the urinary tract in ovarian cancer with low incidence.
Ji Hyun Kim, Dong-eun Lee, Hyeong In Ha, Jae Young Jung, Sung Han Kim, Hyung Ho Lee, Ho Kyung Seo, Sang-Soo Seo, Sokbom Kang, Sang-Yoon Park, Myong Cheol Lim   +10 more
doaj   +1 more source

Intra-Abdominal Desmoplastic Small Round Cell Tumor (DSRCT) and the Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Review

Current Oncology, 2023
Desmoplastic small round cell tumor is a very rare and highly aggressive soft tissue sarcoma, usually presenting with multiple intra-abdominal tumors in young males. Patients present with advanced disease and the overall survival is dismal.
Sophie J. M. Reijers, Caroline C. H. Siew, Niels F. M. Kok, Charles Honoré, Winan J. van Houdt   +4 more
doaj   +1 more source

Validation of three predictive models for suboptimal cytoreductive surgery in advanced ovarian cancer

Scientific Reports, 2021
The standard treatment for advanced ovarian cancer (AOC) is cytoreduction surgery and adjuvant chemotherapy. Tumor volume after surgery is a major prognostic factor for these patients.
A. Llueca, M. Climent, J. Escrig, Paula Carrasco, A. Serra, L. R. G. V. A. K. K. M. N. C. A. I. C. J. P. E. A. R. Gomez-Quiles Játiva Cebrian Bosso Villarin Maiocch, L. Gómez-Quiles, R. Jativa, G. Cebrian, V. Bosso, A. Villarin, K. Maiocchi, K. Delgado-Barriga, M. Rodrigo-Aliaga, N. Ruiz, C. Herrero, A. Francés, I. Beato, C. Ferrer, J. P. Aracil, E. Boldo, A. Boldó, R. Adell   +22 more
semanticscholar   +1 more source

Deliberation on Deferred Cytoreductive Nephrectomy and Postoperative Treatment for Advanced Renal Cell Carcinoma: A Case Report

Case Reports in Oncology, 2022
In a rare case, free from systemic therapy, deferred cytoreductive nephrectomy was implemented in treating an advanced renal cell carcinoma with liver, lung, and splenic colon metastases.
Takuya Nakagawa, Yoshihide Kawasaki, Satoko Sato, Hiromichi Katayama, Yohei Satake, Shuichi Shimada, Takuma Sato, Naoki Kawamorita, Shinichi Yamashita, Koji Mitsuzuka, Atsushi Kohyama, Masaharu Ishida, Hideo Ohtsuka, Michiaki Unno, Akihiro Ito   +14 more
doaj   +1 more source

Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival.

Journal of Clinical Endocrinology and Metabolism, 2021
CONTEXT The role of cytoreduction of adrenocortical carcinoma (ACC) remains poorly understood. OBJECTIVE To analyze the impact of cytoreductive surgery of the primary tumor in patients with metastatic ACC.
V. Srougi, I. Bancos, Marilyne Daher, Jeffrey E. Lee, P. Graham, J. Karam, A. Henriquez, T. Mckenzie, A. Sada, I. Bourdeau, Jonathan Poirier, A. Vaidya, Tiffany Abbondanza, Collen M Kiernan, S. Rao, Oksana Hamidi, Nirupa Sachithanandan, A. Hoff, J. Chambo, M. Almeida, M. Habra, M. C. Fragoso   +21 more
semanticscholar   +1 more source